v3.26.1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 03, 2026
Jul. 04, 2025
Cash flows from operating activities:    
Net income $ 83,225 $ 137,936
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other impairment charges 51,736 36,846
Net gain on sale of property, plant and equipment (60) (5,703)
Stock-based compensation expense 10,382 9,900
Deferred income tax benefit (15,183) (6,761)
Amortization of debt issuance costs 7,304 1,255
Changes in operating assets and liabilities:    
Trade receivables, net (39,541) (49,161)
Inventories, net (51,522) (37,407)
Accounts payable 36,345 23,183
Other operating assets and liabilities (2,348) (28,051)
Net cash provided by operating activities 80,338 82,037
Cash flows from investing activities:    
Purchases of property, plant and equipment (31,448) (16,474)
Proceeds from sale of property, plant and equipment 359 4,732
Acquisitions, net of cash received 1,469,372 86,252
Other investing 0 500
Net cash used in investing activities (1,500,461) (98,494)
Cash flows from financing activities:    
Proceeds from issuance of Preferred Stock, net 171,097 0
Proceeds from issuance of Common Stock, net 139,796 0
Proceeds from borrowings on Senior Notes 1,000,000 0
Payment of debt issuance costs (17,813) 0
Proceeds from borrowings on revolving credit facilities and other 904,267 8,674
Repayments of borrowings on Term Loans 0 (5,000)
Repayments of borrowings on revolving credit facilities and other (730,816) 0
Payment of dividends (12,201) (9,729)
Distributions to noncontrolling interest holders (1,117) (1,174)
Other financing (5,198) (12,418)
Net cash provided by (used in) financing activities 1,448,015 (19,647)
Effect of foreign exchange rates on Cash and cash equivalents 3,736 44,969
Increase in Cash and cash equivalents 31,628 8,865
Cash and cash equivalents, beginning of period 185,863 249,358
Cash and cash equivalents, end of period $ 217,491 $ 258,223